Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News JOHNSON & JOHNSON JNJ

Healthcare
Johnson & Johnson, through its subsidiaries, is engaged in the research and development, manufacture, and sale of a range of products in the healthcare field. The Company's primary focus is products related to human health and well-being. It operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment is focused on various therapeutic areas, including... see more

Recent & Breaking News (NYSE:JNJ)

Johnson & Johnson Reports Q4 and Full-Year 2022 Results

Business Wire January 24, 2023

Johnson & Johnson to Participate in the SVB Securities Global Biopharma Conference

Business Wire January 18, 2023

Johnson & Johnson Completes Acquisition of Abiomed

Business Wire December 22, 2022

Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400

PR Newswire December 19, 2022

Johnson & Johnson Announces Extension of Abiomed Tender Offer to December 21, 2022

Business Wire December 14, 2022

Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Business Wire December 13, 2022

Johnson & Johnson to Participate in the 41st Annual J.P. Morgan Healthcare Conference

Business Wire December 7, 2022

Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board

Business Wire November 30, 2022

Johnson & Johnson to Acquire Abiomed

Business Wire November 1, 2022

Johnson & Johnson Reports Q3 2022 Results

Business Wire October 18, 2022

Johnson & Johnson to Participate in the Credit Suisse 31st Annual Healthcare Conference

Business Wire October 3, 2022

Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company

Business Wire September 28, 2022

Johnson & Johnson Opens State-of-the-Art Science and Technology Campus in San Francisco Bay Area

Business Wire September 20, 2022

Johnson & Johnson Announces $5 Billion Share Repurchase Program

Business Wire September 14, 2022

Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results

Business Wire September 13, 2022

Johnson & Johnson Appoints Larry Merlo as Non-Executive Chair Designate of Planned New Consumer Health Company

Business Wire August 24, 2022

Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science

PR Newswire August 12, 2022

Johnson & Johnson to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

Business Wire August 9, 2022

Mathai Mammen, M.D., Ph.D., Leaves Position as Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson

Business Wire August 8, 2022

Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

Business Wire August 2, 2022